Navigation Links


VZV at medicine products

Varicella Zoster Virus (VZV) IgG EIA

Description:An important aspect of the control of varicella-zoster virus infection is the prevention of contact between susceptible individuals and those with active infection. Antibodies to varicella-zoster have been detected by CF, immunodiffusion, neutralizing antibody, or fluorescent antibody techniques, including the fluorescent-antibody-membrane-antigen (FAMA) assay. The FAMA assay has proven to be v...
Company:Bio-Rad Laboratories

VZV IgG ELISA

Description:Varicella-Zoster Virus (VZV) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to VZV in human sera. Individual serum specimens may be used for the determination of immune status. Paired sera, acute and convalescent, may be used to demonstrate seroconversion or a significant rise in antibody level, as an aid in the diagnosi...
Company:Diagnostic Automation, Inc.

VZV IgM ELISA

Description:Varicella-zoster virus (VZV) IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection of IgM antibody to Varicella-zoster virus in human serum as an aid in the diagnosis of primary infection or reactivation....
Company:Diagnostic Automation, Inc.

Anti-VZV IgG Assay

Description:Inquire...
Company:Scimedx Corporation

RIDASCREEN Anti-VZV IgM Assay

Description:Inquire...
Company:Scimedx Corporation

Varicella-zoster VZV IgG II

Description:Our breadth of infectious disease ELISA products make us a leader in this field. With standard assay protocols for faster integration into the busy laboratory, our Infectious Disease ELISA products provide increased reliability and run-to-run consistency. Our Infectious Disease ELISA menu includes antibody detection assays for a wide range of serological assays including ToRCH, EBV, H. pylori and...
Company:Inverness Medical Innovations

Varicella-zoster VZV IgM

Description:Our breadth of infectious disease ELISA products make us a leader in this field. With standard assay protocols for faster integration into the busy laboratory, our Infectious Disease ELISA products provide increased reliability and run-to-run consistency. Our Infectious Disease ELISA menu includes antibody detection assays for a wide range of serological assays including ToRCH, EBV, H. pylori and...
Company:Inverness Medical Innovations

VZV Antibody, IgM

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

VZV Antibodies, IgG & IgM

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

VZV Antigen Detection

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

VZV Antigen Detection and Culture

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

VZV Antibody, IgG

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

VZV DFA

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

VZV by PCR

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Other TagsLegionellaMicroforceps
(Date:1/7/2009)...years ago, the Chinese National Human Genome Cente...ished ,in the Zhangjiang HiTech Park of Pudong Di...event, ,which marks the beginning of the Genomics...ini-reviews for ,this special issue. We hope that... life science research workers ,to collectively r...
(Date:1/7/2009)...SON, WI, JANUARY 5, 2009 Currently, plant testing...gical risks from chemical pesticides to nontarget ...ure plants. Protection of the plant development an...quired for the protection of animals. Past researc...t plant development/reproduction is not adequately...
(Date:1/7/2009)...ridge, MA January 7, 2009 Phylonix Pharmaceutic... a $1,250,369 Phase II Small Business Innovation R...f General Medical Sciences of the National Institu...ssays for assessing drug effects on Cytochrome (CY...development, is required by the Food and Drug Admi...
(Date:1/6/2009)...IER INTERNATIONAL MEETING HIGHLIGHTS BREAKTHROUGH ...C DIFFERENCES,CAREFREE, AZ,FEBRUARY 3-6, 2009 ,...es in treatment and outcomes among cancer patients...derlying causes and what can be done to solve a se...ion for Cancer Research is hosting a collaboration...
Breaking Biology News(10 mins):Human genomics in China 2Human genomics in China 3Human genomics in China 4Human genomics in China 5Human genomics in China 6Human genomics in China 7Human genomics in China 8Human genomics in China 9Human genomics in China 10Human genomics in China 11NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays 2American Association for Cancer Research hosts Science of Health Care Disparities Meeting 2Alcohol and malt liquor availability and promotion higher in African American inner cities 2734 1Alcohol and malt liquor availability and promotion higher in African American inner cities 2734 2China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent 15858 1China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent 15858 2Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 1Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 2Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 3Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 4Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 1Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 2Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 3Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 4
(Date:1/7/2009)... Applauds Legislation Aimed at Protecting Medicare...h Congress , , ALEXANDRIA, Va., Jan. 7 Physi...uld no longer be limited by arbitrary financial ca...ate and House of Representatives, according to the... , The Medicare Access to Rehabilitation Services ...
(Date:1/7/2009)...llowing is a statement by Lois Aronstein, AARP NY ...e of the State address put forth recommendations o...lth care and financial security of New Yorkers of ...osing to expand the Family Health Plus Program to ...ore than 400,000 additional New Yorkers eligible f...
(Date:1/7/2009)...ied mutations in a gene that predict a high likeli...ic leukemia (ALL). Although the researchers cautio... changes in the gene, called IKZF1 or IKAROS, lead...rovide the basis for future diagnostic tests to as...lecular test to identify this genetic marker in AL...
(Date:1/7/2009)...n. 7 Stryker Corporation,(NYSE: SYK ) announced...nvestor,conference: , , January 14, 200...al J.P. Morgan Healthcare Conference, S...cast of the Company,s presentation will be availab...he For Investors page. The,presentation for the J...
Breaking Medicine News(10 mins):Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3Health News:Gene abnormality found to predict childhood leukemia relapse 2Health News:Gene abnormality found to predict childhood leukemia relapse 3Health News:Gene abnormality found to predict childhood leukemia relapse 4Health News:Stryker To Present at Investor Conference 2
Other Contentsbandbandbandbandbandbandbandbandbarkbarkbarkbarkbasesbasesbasesbasesbasesbasesbasophilsbasophilsbicepsbicepsbellybellybellybellybicuspid